Autolus Therapeutics (AUTL) Amortization of Deferred Charges (2024 - 2025)
Autolus Therapeutics (AUTL) posted quarterly Amortization of Deferred Charges of $825000.0 for Q3 2025, down 30.73% year-on-year from $1.2 million in Q3 2024, and down 30.73% on a QoQ basis from $1.2 million in Q3 2024.
Autolus Therapeutics (AUTL) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Amortization of Deferred Charges for 2 consecutive years, with $825000.0 the latest figure, recorded in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | 405.86 Mn | 105.15 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 825,000.00 |
| Sep 30, 2025 | 825,000.00 |
| Sep 30, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.19 Mn |